Featured Editor

World-renowned expert in IVF, and on the editorial boards of Human Reproduction Reproductive Biotechnology Online

Dr Cummins在西澳大利亚Murdoc大学从事解剖学、人类生物学和繁殖生物技术的教学工作。在繁殖生物学和辅助生殖技术（如：体外授精）领域拥有丰富的经验。现在多个知名期刊（包括“Human Reproduction and Reproductive Biotechnology Online”）担任编辑，任西澳大利亚繁殖技术理事会科学咨询委员会主席一职（负责监督IVF诊所的政府机构）。10多年来，一直从事专业编辑工作，编辑了2500多篇论文。在亚洲拥有从多同事和朋友，曾在2005年任Osak大学染色体组信息研究中心客座教授。 2009年开始在理文从事编辑工作。

Dr Cummins teaches Anatomy, Human Biology and Reproductive Biotechnology at Murdoch University in Western Australia. He has extensive experience in reproductive biology and assisted conception techniques such as in vitro fertilization (IVF). He sits on the editorial board of several top journals, including Human Reproduction and Reproductive Biotechnology Online, and chairs the Scientific Advisory Committee of the Reproductive Technology Council of Western Australia (the government body overseeing IVF clinics). He has been involved in professional editing for 10 years and has worked on about 2500 papers. He has many colleagues and friends in Asia and was a Visiting Professor at Osaka University's Genome Information Research Center in Japan in 2005. Assoc Prof Cummins began editing for the Edanz Group in 2009.

Featured Editor

Published over 160 journal articles, book chapters, conference papers, patents and reports

Dr Fee，新西兰Canterbury大学化学工程系教授，主攻生物工程、生物化学与生物分子工程。博士研究课题是颈动脉中的血流干扰以及与动脉粥样硬化的联系。在加拿大Waterloo大学1989/90届的博士后研究生期间，从事超滤膜研究，回到新西兰后，在Waikato大学担任讲师，同时任新西兰肉类食品研究院生物化学工程员。从1996年开始，一直担任新西兰Waikat大学的全职讲师，2003年—2006年任材料和工艺工程系主任，期间曾担任Canterbur大学化学工程系主任。在蛋白质纯化、蛋白质PEGylation、膜分离和过程色谱法领域拥有丰富经验，一直从事控制药物释放、微囊法和高价值乳蛋白质纯化的研究。现任Canterbury大学生物分子交互作用研究中心主任，专注于表面等离子共振技术领域的研究。发表了160多篇化学工程学术期刊文章、专书论文、研讨会论文、专利与行业研究报告。2008年开始在理文编辑担任化学工程和生物工程编辑。

Dr Fee is a professor of chemical engineering at the University of Canterbury, with expertise particularly in biotechnology, biochemical and biomolecular engineering. His PhD topic was on blood flow disturbances in the carotid artery and their links to atherosclerosis. He was a post-doctoral fellow at the University of Waterloo, Canada, in 1989/90, working on membrane ultrafiltration. He then returned to NZ as a lecturer at the University of Waikato, and a biochemical engineer at the Meat Industry Research Institute of New Zealand (MIRINZ). A full-time lecturer at the University of Waikato from 1996, he was head of the Department of Materials and Process Engineering from 2003 until 2006, when he took up a chair in chemical engineering at the University of Canterbury. Dr Fee has a wide range of experience in protein purification, protein PEGylation, membrane separations and process chromatography, and has worked in controlled drug delivery, microencapsulation and high-value dairy protein purifications. He is Director of the Biomolecular Interactions Centre at the University of Canterbury and has expertise in surface plasmon resonance. Dr Fee has published over 160 journal articles, book chapters, conference papers, patents and industrial research reports across a wide range of chemical engineering topics. Dr Fee began working with Edanz Editing as an editor in fields associated with chemical engineering and biotechnology in 2008.

Dr. Devon 是一名生物学家，致力于神经系统科学和遗传学。她于1996年取得了精神疾病遗传学的博士学位。随后在加拿大温哥华以及英国的爱丁堡开始了博士后的深造，主要研究运动神经元疾病 (Lou Gehrig's Disease，洛盖赫里格病 ) 的一种罕见遗传形式。她著有50余篇研究论文、专书论文、评论和经费申请，曾为分子生物学期刊审稿。Dr. Devon 从2008年起为理文编辑工作。

Dr Devon is a biologist with a special interest in neuroscience and genetics. She is a graduate of the University of Cambridge, United Kingdom, and obtained her PhD in 1996 from the University of Edinburgh, UK, in the genetics of psychiatric illness. She undertook post-doctoral research on a rare, inherited form of Motor Neurone Disease (Lou Gehrig's Disease) in Vancouver, Canada, and then started her own research group back in Edinburgh, UK, investigating the genetics, cell biology and biochemistry of motor neurone disease. She is a co-founder of the Euan MacDonald Centre for Motor Neurone Disease Research at the University of Edinburgh. Dr Devon has written over 50 research papers, book chapters, reviews and successful grant applications, and has peer-reviewed manuscripts for molecular biology journals. Dr Devon began working with Edanz Editing in 2008.

生物学家，以神经系统科学、发育生物学以及遗传学领域见长。他在博士阶段主要研究影响肢体发育的小鼠基因突变相关的分子遗传分析。从1996年到 2004年，Dr. Allen 一直在英国剑桥Babraham 研究所神经生物学部门从事研究工作，包括DNA/RNA操纵、提纯/分离、电泳、PCR、克隆、印迹工作、文库筛选、遗传图绘制、转基因设计与构建、人工染色体工程、用于ES细胞基因打靶的载体设计与构建、细胞培养、切片技术、小鼠行为分析、小动物外科手术以及序列数据库和分析工具等生物信息工具的研究。 Dr. Allen 从2007年开始为Edanz Editing 工作，主要编辑神经系统科学和遗传学领域的文章。

Dr Allen is a biologist with particular experience in the fields of neuroscience, developmental biology and genetics. His PhD topic involved molecular genetic analysis of mouse mutations that affect limb development. From 1996 to 2004, Dr Allen was a researcher at the Department of Neurobiology, Babraham Institute, Cambridge, UK. Dr Allen’s research skills and techniques include DNA/RNA manipulation and purification/isolation, electrophoreses, PCR, cloning, all blottings, library screening, genetic mapping, design and construction of transgenes, artificial chromosome engineering, design and construction of vectors for gene targeting in ES cells, cell culture, histological techniques, mouse behavioral analysis, small animal surgery, and bioinformatic tools such as sequence databases and analysis tools. Dr Allen began working with Edanz Editing as an editor in fields associated with neuroscience and genetics in 2007.

Featured Editor

Has published 24 papers in international peer-reviewed journals and has co-authored scientific book chapters; molecular biophysics specialist

生物信息学家，在DNA/蛋白数据库注释、序列分析和分子建模领域拥有丰富经验。Dr Biswas从事了七年的博士后研究，利用分子建模技术研究蛋白配基结合。此后进入印度科学研究院新成立的生物信息学中心，任高级科学主任，负责培训课程和研究项目的开发。1998年回英，任剑桥大学欧洲生物信息研究院任数据库主管，负责数据库的创建、注释和研究。2002-2009年期间，在新西兰一家私营公司从事生物信息学工作。曾从事多个项目的研究，了解基因与其他因素如何相互作用从而影响动植物复杂的生物学特性。Dr Biswas生于苏格兰，母语为英语，拥有丰富的写作和出版经验。已在国际同行评审期刊上发表24篇论文，并合作撰写了一些专书论文。自2010年起为理文编辑工作。

Dr Biswas is a bioinformatics scientist with experience in DNA/protein database annotation, sequence analysis and molecular modeling. For seven years Dr Biswas was a Post-Doctoral Research Associate using molecular modeling techniques to study protein-ligand binding. She then joined the newly formed Bioinformatics Centre at the Indian Institute of Science as a Senior Scientific Officer responsible for the development of training courses and research projects. Dr Biswas returned to the UK in 1998 as a Database Curator at the European Bioinformatics Institute, Cambridge, where she was involved in database production, annotation and research. From 2002 to 2009, Dr Biswas worked as a Bioinformatics Scientist for a private company in New Zealand. She worked in a range of projects aimed at understanding how genes and other factors interact to influence complex biological traits in animals and plants. Dr Biswas, a Scottish-born native speaker of English, has extensive writing and publication experience. She has published 24 papers in international peer-reviewed journals and has co-authored scientific book chapters. Dr Biswas began editing for the Edanz Group in 2010.

Dr. Dingley 主要致力于生物化学领域，特别是蛋白质结构和功能特性领域的研究。具有15年以上论文写作以及在有较高影响因子的国际期刊中发表的经验。同时，他也一直在从事科技专书论文的写作，并且担任 Biochemical Journal 的编委。Dr. Dingley 从2008年起为理文编辑工作。

Dr Dingley’s research is broadly in the area of biochemistry, with particular interest in characterizing protein structure and function. Dr Dingley has over 15 years' experience in publishing articles in international high-impact journals. He has written scientific book chapters, and is an editor on the editorial advisory board for the Biochemical Journal. Dr Dingley began as an editor for Edanz Editing and Liwen Bianji (Edanz Editing China) in 2008.

Featured Editor

Experienced bioinformatics analyst with specific experience in DNA/protein sequence data

在过去的十年里，Dr. Stewart一直在爱丁堡大学和格拉斯哥大学从事博士后研究工作，主要致力于分子生物学研究，包括基因组工程相关的各类基因的测序和分析工作。Dr. Stewart是经验丰富的生物信息分析员，特别在是DNA/蛋白质序列数据领域。2001年至2007年期间，Dr. Stewart担任位于格拉斯哥的Thomson Scientific (汤姆森科技信息集团) Geneseq (基因数据库) 小组的高级分析员。Dr. Stewart从2007年开始为Edanz Editing工作，主要编辑分子生物学领域，特别是基因组方面的文章。

For 10 years, Dr Stewart was a Post-Doctoral Research Scientist at Edinburgh and Glasgow Universities, involved in molecular biology research that included sequencing and analysis of various genes for genome projects. Dr Stewart is an experienced bioinformatics analyst with specific experience in DNA/protein sequence data. From 2001 to 2007, Dr Stewart was a Senior Analyst in Thomson Scientific’s GENESEQ team based in Glasgow. Dr Stewart began as an editor for Edanz Editing in 2007, working in molecular biology fields with an emphasis on genomics.

Featured Editor

PhD in microbiology from the University of Oxford

Dr Fox拥有牛津大学微生物学博士学位，攻读博士学位期间主要研究流感嗜血杆菌生物合成基因中的新型相变脂多糖。此后，在澳大利亚昆士兰大学从事5年博士后研究，重点研究DNA甲基转移酶在细菌病原体基因调节中的作用，其他项目包括：兽医病原体活性减毒疫苗的设计与开发。以第一作者的身份在微生物病原领域的高级期刊杂志上发表了多篇文章。现为一名全职编辑，拥有广泛的生物学科经验，包括分子生物学，微生物学，生物技术，基因组学，流行病学，生物化学和医学。2009年起为理文编辑工作。

Dr Fox completed a PhD in microbiology at the University of Oxford, investigating novel phase variable LPS biosynthetic genes in Haemophilus influenzae. She then spent five years as a post-doctoral researcher at the University of Queensland, Australia, focusing on the role of DNA methyltransferases in gene regulation in bacterial pathogens. Other projects included the design and development of live, attenuated vaccines for veterinary pathogens. She has many first-author publications in high-ranking journals in the area of microbial pathogenesis. Dr Fox is now a full-time editor, with extensive editing experience in a broad range of biological disciplines including molecular biology, microbiology, biotechnology, genomics, epidemiology, biochemistry and medicine. Dr Fox began editing with the Edanz Group in 2009.

Dr Morris拥有肿瘤学（特别是放射生物学、放射线疗法、化学疗法）专业背景。曾在牛津大学作为科研人员和首席研究员，研究癌症新药和新式放疗法的开发。近期作为医学作者和科研员，从事于生物技术的研究和著书。涉及的诊疗领域包括肿瘤、传染病、增龄性黄斑变性和肥胖。曾作为访问学者在美国Brookhaven国家实验室工作。曾在同行审查期刊杂志发表50多篇文章及专书论文。2009年开始为理文编辑工作。

Dr Morris’s scientific background is oncology with an emphasis on radiobiology, radiotherapy and chemotherapy. During the period that he worked as a scientist and principal investigator at the University of Oxford, the focus of Dr Morris’s research was on the development of new drugs and novel forms of radiotherapy for the treatment of cancer. More recently, Dr Morris has worked as a medical writer and scientist in the biotechnology industry. Therapeutic areas that he has been involved with include oncology, infectious diseases, age-related macular degeneration and obesity. Dr Morris has visiting scientist status at the Brookhaven National Laboratory in the US. Dr Morris has written over 50 peer-reviewed journal articles and book chapters. Dr Morris began working with the Edanz Group in 2009.

Featured Editor

Previously worked in a biotechnology company that focused on a radioactive peptide as targeted therapy for neuro-oncology

Dr Schade-Bijur的博士学位研究重点是确定人类大脑神经细胞钠离子通道的启动区，研究成果已在神经科学学会的一次国际会议上宣讲，并在同行评审期刊上发表。拥有精湛的高度分子生物学领域技术，包括：克隆、基因、DNA和蛋白质提取、RT - PCR检测、杂交、测序和凝胶电泳。曾在一家生物技术公司工作7年，重点研究神经肿瘤靶向治疗放射肽。作为科学家和高级制造经理，针对各种组织进行了生理组织学实验（包括使用组织切片机备制切片），研究卵母细胞的提取和神经胶质瘤氯离子通道。另外还负责临床药学，是编写基金申请和规范性文件的临床小组成员。发表了基于实践经验的两篇同行评审论文（包括临床试验论文）。作为一名自由撰稿人，其写作领域涉及卫生经济学和医学教育（关于癌细胞血管生成），撰写了50多份脂质产品技术公告。科技写作背景丰富，2010年加盟理文编辑，主要从事神经学和肿瘤领域的撰稿和编辑。

Dr Schade-Bijur’s PhD focused on identifying the promoter region of a neuronal sodium channel in the human brain. Dr Schade-Bijur’s work from these studies has been presented at an international Society of Neuroscience meeting and published in peer-reviewed journals. She is highly skilled in molecular biology techniques, such as cloning, mRNA, DNA and protein extraction, RT-PCR, blotting, sequencing and gel electrophoresis. For seven years Dr Schade-Bijur worked in a biotechnology company that focused on a radioactive peptide as targeted therapy for neuro-oncology. As a scientist and the Senior Manager for Manufacturing, Dr Schade-Bijur performed histology experiments for various tissues, including using a microtome for tissue slice preparation, and oocyte extraction and electrophysiology on a glioma chloride channel. Dr Schade-Bijur was also in charge of the clinical pharmacy and was part of the clinical team writing grants and regulatory documents. From this research she published two more peer-reviewed papers, including a clinical trial paper. As a freelance writer, Dr Schade-Bijur has written in the areas of health economics, medical education regarding cancer angiogenesis and over 50 technical bulletins about lipid products. Dr Schade-Bijur has a particularly broad science and writing background. She joined the Edanz Group as a writer and editor in 2010, specializing in the fields of neuroscience and oncology.

1997年开始为非英语母语作者的文稿编辑，2004年起为理文编辑工作。其科学研究领域多样化，主要致力于化学 (有机,、有机金属、无机、表面化学)、半导体、生物 (传感器、DNA和蛋白质阵列) 纳米技术。 1996年7月担任东京大学特别研究员，从事新型催化反应途径研究，通过该途径可以在比目前工业应用中更容易实现的条件下生成氨 。现居英国，同时为理文编辑工作，仍活跃在生物纳米传感器的研究中。

Dr Wright has been editing scientific manuscripts for non-native authors since 1997 and has been an editor for Edanz Editing since 2004. His scientific background is diverse, with the main scientific fields being in chemistry (organic, organometallic, inorganic and surface), semiconductors, biosensors (transducers, DNA and protein arrays) and nanotechnology. In 1996/7, Dr Wright was a Post-doctoral Fellow at The University of Tokyo, Japan, investigating novel catalytic pathways capable of generating ammonia under milder conditions than presently used in industry. As well as working for Edanz Editing, Dr Wright, now based in the UK, continues as a research scientist in the field of bionanosensors.

Dr. Davies是一位生物学家，专攻神经系统科学、肿瘤学、染色质结构以及基因表达等领域，在法国波尔多 Université Bordeaux II 大学 François Magendie Institute for Neuroscience、澳大利亚Children’s Cancer Institute等多家研究机构从事过博士后研究工作，期间研究了人β-珠蛋白基因簇染色质结构以及顺铂损伤等课题。Dr. Davies曾担任过几家国际期刊的审稿人，编辑了大量英语母语及非母语作者的稿件。他也以第一作者的身份发表过多篇文章，如“Nucleic Acids Research and The Journal of Pharmacology and Experimental Therapeutics”。他具备丰富的实验室工作经验，包括：急性器官型培养、腺病毒操纵、脑片慢病毒操纵和转导以及神经细胞培养、荧光共焦显微技术、细胞显微注射、活体小鼠模型、蛋白质印迹、电泳凝胶迁移率检测、多种PCR、克隆以及细菌质粒生成等。Dr Davies 从2006年开始为Edanz Editing工作。

Dr Davies is a biologist with particular expertise in the areas of neuroscience, oncology, and chromatin structure and gene expression. Dr Davies has held Postdoctoral Fellow positions at a number of institutes including the François Magendie Institute for Neuroscience, Bordeaux, France, and the Children’s Cancer Institute Australia. During his PhD, he examined chromatin structure and cisplatin damage at the human beta-globin gene cluster. Dr Davies has been a regular reviewer for several international journals and has edited numerous manuscripts written by both native and non-native English speakers. He has a number of first-author publications in journals such as Nucleic Acids Research and The Journal of Pharmacology and Experimental Therapeutics. Dr Davies has experience in a wide variety of laboratory techniques, including acute and organotypic culture, adenovirus manipulation, lentivirus manipulation and transduction of brain slices and cultured neuronal cells, fluorescent and confocal microscopy, cell microinjection, in vivo mouse models, western blot, electrophoretic gel mobility shift assay, PCR (most varieties), cloning and bacterial plasmid production. Dr Davies began working as an editor for Edanz Editing in 2006.

Featured Editor

Specialist medical writer and endocrinology expert

Dr. Smith 的博士论文标题为：“The Role of PPARalpha in Modulating Glucose Tolerance and Insulin Action using In Vivo Models of Insulin Resistance”。 一直担任 Queen Mary, University of London 细胞与分子科学研究所研究助手，并着重于糖尿病及相关代谢疾病的生物化学的研究。同时担任 London Sport Institute 研究员。曾在 London School of Journalism 进修过与出版相关的编辑和设计课程，现为全职医学作者。Dr. Smith 在全球知名机构 Medicus International 任职期间，通过与多家著名制药公司合作的医学交流项目积累了大量的医学和科学交流经验。2006年起加入理文编辑，凭借着广泛的研究背景以及出色的医学写作经验帮助客户达到顺利发表的目标。

Dr Smith’s PhD thesis was entitled “The Role of PPARalpha in Modulating Glucose Tolerance and Insulin Action using In Vivo Models of Insulin Resistance”. Dr Smith has been a Research Assistant at the Queen Mary, University of London’s Institute of Cellular and Molecular Sciences, where he focused on the biochemistry of diabetes and related metabolic disorders. He has also been a Research Fellow at the London Sport Institute, part of Middlesex University. Dr Smith has studied editing and design skills in relation to publication at the London School of Journalism, and is now a full-time medical writer. Dr Smith gained extensive experience in medical and scientific communications while employed at the internationally recognized agency Medicus International, where he worked on a range of medical communications projects for several well-known pharmaceutical companies. He joined the Edanz Group in 2006, where he is able to apply his wide research background and expertise in the medical communications sector in assisting clients to achieve their publication goals.

Dr Roth发表的文章涉及以下领域：T细胞生物学、基因重排的分子机制、发育生物学、神经生物学、核受体生物学。在转基因动物模型、开发基因组和蛋白质组技术、运用基因和蛋白质表达谱方法进行疾病诊断和治疗（包括糖尿病、肥胖、血液疾病和肿瘤）等方面拥有丰富经验。联合撰写并在影响力极高的杂志上发表了13篇文章，同时还和专利发明人联合撰写了5篇专利书。曾为知名生物制药、医疗设备和生物科技等公司提供有关平台技术和产品开发方面的顾问建议。多年担任昆尼皮亚克大学客座教授，在线授课生物学本科课程。在美国西北大学期间，获美国癌症学会博士后奖学金；在纽约冷泉港期间，研究发育神经生物学。于2010年开始为理文编辑工作，担任编辑。

Dr Roth has published articles on T cell biology, the molecular mechanisms of gene rearrangement, hematopoeisis, developmental biology, neurobiology, and nuclear receptor biology. He has extensive experience with transgeneic animal models, developing genomic and proteomic based technologies, and applying gene and protein expression profiling methods to diseases and therapeutic areas, including diabetes, obesity, blood disorders, and oncology. He is a co-author on 13 publications in high impact journals, and the co-inventor on five issued patents. He has consulted with leading biopharmaceutical, medical device, and life science companies on new platform technologies and product development. As an adjunct professor at Quinnipiac University, he taught an undergraduate online biology course for several years. He received an American Cancer Society Postdoctoral Fellowship while at Northwestern University, and studied developmental neurobiology at Cold Spring Harbor, New York. Dr Roth began working with Edanz Editing as an editor in 2010.

Featured Editor

Enzymology expert

Dr Devenish目前的研究方向是四级结构在酶功能中的作用。有机化学博士学位的研究领域是天然产物分离和半合成，还大量涉及肽合成和高分子化学。最近的研究领域是酶学，研究酶的生物化学和生物物理特性、分子克隆技术和定点突变。Dr Devenish一直从事研究工作，发表了大量科技文章。于2009年起为理文编辑工作。

Dr Devenish's current research examines the role of quaternary structure in enzyme function. His PhD was obtained in organic chemistry, in the field of natural products isolation and hemisynthesis, and also involved significant amounts of peptide synthesis as well as polymer chemistry. Dr Devenish’s recent research has been in the field of enzymology, where he has worked on biochemical and biophysical characterization of enzymes, molecular cloning techniques and site-directed mutagenesis. Dr Devenish continues in active research, and has a successful publication record. Dr Devenish started working with the Edanz Group in 2009.

Dr Fayle的博士研究领域是食品化学，后在英国雷丁大学食品与营养学系从事博士后研究。曾作为新西兰农作物和食品研究院工作。实验室工作经验包括：传统凝胶电泳和毛细管电泳技术、高效液相色谱法、有机合成、蛋白质提纯与鉴定、核磁共振。拥有美拉德反应的专业知识，并以皇家化学学会作者身份发表过针对这一反应的专论。撰写了20篇相关内容的出版物，并受邀在该研究领域的国际会议上发言。自2010年起为理文编辑工作，担任编辑。

Dr Fayle’s PhD focused on Food Chemistry. Her postdoctoral research was done in the Department of Food and Nutrition at the University of Reading, UK. She then worked as a scientist for Crop and Food Research in New Zealand. Dr Fayle’s laboratory skills include both traditional gel electrophoresis and capillary electrophoresis techniques, HPLC, organic synthesis, protein purification and identification, and NMR. Dr Fayle has expert knowledge of the Maillard Reaction, and is the author of a Royal Society of Chemistry monograph on this reaction. She also has authored twenty related publications, and has been an invited speaker at international conferences in her field of study. She began working with the Edanz Group as an editor in 2010.

Dr Sheen目前为圣迭戈州立大学博士后研究员，从事微生物致病的研究。工作内容包括微生物生境和血脑屏障渗透。她拥有MRSA感染新药治疗方法的两项开发专利。于新西兰皇家农业研究所（新西兰林肯郡）完成博士研究，研究重点是运用基因技术改良微生物生物防治剂的生存土壤。其它研究包括：南极抗冻鱼系统发育分析和物种进化研究。从2011年起在理文编辑担任编辑工作。

Dr Sheen is a postdoctoral research fellow at San Diego State University, studying microbial pathogenesis. Her work encompasses microbial niche establishment as well as penetration of the blood-brain barrier. She also has two patents for the development of novel therapeutic agents for treatment of MRSA infections. Dr Sheen carried out her PhD research at AgResearch in Lincoln, New Zealand, focusing on applying genetic techniques to improve the soil survival of a microbial biocontrol agent. Her other research has involved the phylogenetic analysis of Antarctic notothenioid fish and species evolution. Dr Sheen began editing for Edanz Editing in 2011.

Dr Parker的博士研究领域是癌生物学和信号传导，后在佛罗里达大学射线肿瘤科从事博士后研究。现为New York Journal of Books科技文章审稿人。2010年开始为理文编辑工作，担任医学作者和编辑。

Dr Parker’s PhD studies were in the field of cancer biology and signal transduction. Her post-doctoral research was in the Department of Radiation Oncology at the University of Florida. Dr Parker is presently a science reviewer with the New York Journal of Books. She began working with the Edanz Group as a medical writer and editor in 2010.

Dr Jefferies在分子寄生虫学方面经验丰富，主要领域是新发传染病研究，目前是英国布里斯托尔大学生物科学和兽医学学院的研究科学家。发表了20多篇研究论文，是多家杂志寄生虫学和兽医学文章审稿人。无论在学术化还是商业化研究环境，Dr Jefferies都拥有丰富经验，拥有以下领域的专业知识：新型诊断方法，分子流行病学，种群遗传学，系统发育学，分子分类学和蛋白质表征。还参与了利用酵母双杂交系统发现多肽药物的研究。于2010年开始为理文编辑工作，担任编辑。

Dr Jefferies has extensive research experience in molecular parasitology with a particular interest in emerging infectious diseases. He is currently working as a research scientist at the University of Bristol, UK, in the Schools of Biological Sciences and Veterinary Science. Dr Jefferies has published more than 20 research papers and is a reviewer for multiple journals in the fields of parasitology and veterinary science. With experience in both academic and commercial research environments, Dr Jefferies has expertise in the development of novel diagnostic methods, molecular epidemiology, population genetics, phylogenetics, molecular taxonomy and protein characterization. He has also worked on peptide-based drug discovery using yeast two-hybrid systems. Dr Jefferies began working with the Edanz Group as an editor in 2010.

高级工艺化学工程师，在农业部门工作，这份工作需要对跨化工各领域有广泛深入的了解。在有机化学和物理有机化学领域拥有丰富经验，特别是合成、机理和动力学。2005年获博士学位，与国际知名教授Prof Lloyd-Jones共同研究，在二烯和烯炔复分解新型催化剂的开发和理解的基础上做进一步研究。曾多次出席专题研讨会上并发言，论文多次获奖，最近又与他人联合撰写了一篇向《欧洲化学》投稿的重要文章。于2010年开始为理文编辑工作，担任编辑。

Dr Alan Robinson is a senior process chemist working in the agricultural industry. His work requires a deep understanding across a wide range of chemical fields. He has extensive experience in organic and physical organic chemistry, especially with respect to synthesis, mechanism and kinetics. Dr Robinson completed his PhD, based on the development and understanding of new catalysts for diene and enyne metathesis, with internationally acclaimed Prof Lloyd-Jones in 2005. He has spoken and presented prize winning posters at numerous symposia, and recently co-authored an important paper in Chemistry – A European Journal. Dr Robinson began working with the Edanz Group as an editor in 2010.

Dr March是癌症生物学家，主要研究领域是细胞信号传导和肠道肿瘤学。博士课题内容是研究MAP激酶通路对AP- 1蛋白的调节。目前任英国剑桥大学肿瘤研究所高级博士后研究员，工作重点是应用新模型来判定和表征大肠癌的新驱动基因。此前在英国Babraham研究所做博士后研究，工作内容是与UCB制药公司合作，研究癫痫药物的作用模式。另外还曾在生物技术行业工作。多次受邀在国内和国际上讲学，并在一些国际同行评审期刊发表过文章2011年初加入理文，担任编辑。

Dr March is a cancer biologist with special interests in cell signaling and intestinal oncology. Her PhD research examined the regulation of AP-1 proteins by MAP kinase pathways. Dr March is currently a Senior Postdoctoral Research Fellow at the Cancer Research UK Cambridge Research Institute, where her work focuses on the application of innovative models to identify and characterize novel driver genes in colorectal cancer. Previously, Dr March was a Postdoctoral Research Scientist at the Babraham Institute, UK, where, in collaboration with UCB Pharma, she studied the mode of action of an anti-epilepsy drug. She also has experience working in the biotechnology industry. Dr March has given invited lectures both nationally and internationally, and has published in several international peer-reviewed journals. Dr March joined Edanz as an editor in early 2011.

Dr. Apricó 的博士论文题为“[3H]4-methylglutamate as a novel radioligand for the brain glutamate transporters”。2003年至2005年间，Dr. Apricó在瑞典哥德堡大学 Arvid Carlsson Institute 与Dr. Michael Nilsson一起从事博士后研究工作，主要研究反应性星形胶质化的体外模式。2005年后，一直担任大学药理学和生理学的讲师工作，并于2009年年中重返校园攻读医学学位。Dr. Apricó从2008年起开始为理文编辑工作。

Dr Aprico's doctoral thesis was \[3H]4-methylglutamate as a novel radioligand for the brain glutamate transporters. From 2003 to 2005 Dr Aprico held a post-doctoral position at Arvid Carlsson Institute Göteborg Sweden working with Dr Michael Nilsson investigating in vitro models of reactive astrogliosis. Since 2005 Dr Aprico has been a university lecturer in pharmacology and physiology but returned to university to obtain her medical degree in mid-2009. Dr Aprico began as an editor with the Edanz Group in 2008.

专业背景为生物化学，重点研究海洋无脊椎动物和哺乳动物皮肤内的脂质生化途径。博士研究方向是通过放射性同位素示踪、结构分析和比较生物化学研究，描述马属动物产生皮脂的生化途径。博士后研究课题是将马皮脂巨环内酯和哺乳动物皮肤表皮防水层联系起来。Dr Colton是一位通才科学家，同时还是大学教授，教授课程包括：无机化学、有机化学、生物化学、分子生物学、核物理学和天文学。多次指导同事和学生撰写论文、报告和学术文章并进行校对。已在在同行评审刊物上发表13篇论文，从2007年开始担任编辑。2009年供职理文编辑，从事编辑工作。

Dr Colton's research background in biochemistry focused on lipid biochemical pathways in marine invertebrates and mammalian skin. His doctoral thesis involved describing the biochemical pathways for sebaceous lipid production in the genus Equus through radio-label, structural analysis, and comparative biochemical studies. His post-doctoral work involved relating the giant ring lactones of equine sebum to the epidermal water barrier of mammalian skin. Dr Colton is a generalist scientist and, as a college professor, taught courses from inorganic and organic chemistry to biochemistry and molecular biology to nuclear physics and astronomy. He has advised and edited numerous theses, papers, and articles for colleagues and students. He has published 13 papers in peer-reviewed journals and has been an active editor since 2007. Dr Colton began editing for the Edanz Group in 2009.

Featured Editor

Edanz Science Director. Former Associate Editor at Nature Reviews Neuroscience.

Dr. McGowan曾多次在职业生涯中获奖，其中包括2003年获得 EU Marie Curie Postdoctoral Fellowship。一直从事帕金森疾病的实验室研究及分子机制和有关亨廷顿舞蹈病的研究，结合激光微解剖，微量检测分析和蛋白质组学。他的研究还涉及在正常衰老进程中所发生的分子变化过程的微阵列基因表达分析，以及这些过程如何受到精神活动的影响。他深入了解神经退化疾病、神经功能、海洋动物学、分子生物学、细胞蛋白质生物化学，包括具有功能基因组和细胞成像的传统与现代技术蛋白质组学的广泛的多学科实验技术。Dr. McGowan具有出色的书面写作能力以及丰富的演讲经验，以第一作者的身份发表了多篇文章。2006年初加入理文编辑之前，曾担任Nature Reviews Neuroscience副编辑。Dr McGowan现任理文编辑科学总监。

Dr McGowan has won many awards during his career, including in 2003 the EU Marie Curie Post-doctoral Fellowship. He has worked in laboratories investigating the molecular mechanisms in Parkinson’s disease as well as those involved in Huntington’s disease, combining laser micro-dissection, microarray analysis and proteomics. Further study involved micro-array gene expression analysis of molecular processes occurring during normal aging and how these are affected by mental exercise. Dr McGowan has an in-depth knowledge of neurodegenerative diseases, neural function, marine zoology, molecular and cellular biology and protein biochemistry, along with extensive multi-disciplinary laboratory experience of contemporary and traditional techniques including proteomics, functional genomics and cell imaging. His excellent written and oral communication skills are demonstrated by several first author publications. From 2005 to October 2006, Dr McGowan was an Associate Editor at Nature Reviews Neuroscience before becoming a full-time editor for Edanz Editing. Dr McGowan is the Edanz Group Science Director.

Featured Editor

Bacteriology specialist with 15 published articles

Dr Anderson的博士研究主题是“羊血液中分离出的抗菌肽”。博士学习期间，曾三度荣获奖学金，研究成果曾在7家同行审查期刊上刊登。曾获研究奖金，研究共生菌对肠黏膜屏蔽功能的影响。现为高级科研员，正在对细菌在食品与宿主细胞之间相互作用中的影响作用（特别是对人类肠健康的影响）进行研究。发表有15篇科技文章、20篇技术会议宣讲/张贴论文、5份专利书。2010年加入理文编辑，从事写作和编辑工作。

Dr Anderson’s PhD Thesis was entitled “Antimicrobial Peptides isolated from ovine blood”. During her PhD studies, Dr Anderson was awarded three study scholarships and her work resulted in seven peer-reviewed journal publications. She was also granted a Fellowship to study the effect of commensal bacteria on intestinal barrier function. Dr Anderson is currently a senior research scientist studying the role of bacteria in the interactions between foods and host cells, in particular the effect these have on human intestinal health and wellness. Dr Anderson is the author of 15 published scientific papers, 20 conference presentations/posters and five patents. She joined Edanz Group as a writer and editor in 2010.

Dr. Curtis 的博士论文标题为"Neural Progenitor Cells in Huntington's Disease Human Brain"，现任瑞典University of Goteborg的博士后研究员，研究神经退化疾病。他在多家国际一流杂志中发表过大量的研究报告，其中包括2007年出版的 Science 杂志的一期封面文章。曾在多个国家做有关神经病学领域学术问题的特约报告。Dr. Curtis从2006年初开始为Edanz Editing工作，凭借着深厚的实验室工作经验和和造影知识，主要编辑生物医学领域的文章。

Dr Curtis’s PhD thesis was entitled “Neural Progenitor Cells in Huntington’s Disease Human Brain.” He is currently a Post-doctoral Research Fellow studying neurodegenerative disorders. Dr Curtis has authored many published reports in several leading international journals including the cover article for an issue of Science in 2007. He has given invited lectures in several countries, presenting topics associated with the field of neurology. Dr Curtis began editing for Edanz Editing in early 2006 and works in a very broad area of the biomedical sciences, applying his extensive knowledge of laboratory and imaging procedures.

Dr. Dean的博士论文题目是“Endogenous Neural Excitation and Inhibition and the Evolution of Preterm Brain Injury”。目前正在从事神经系统科学领域的博士后研究工作。具有大型动物和胎儿外科手术经验，包括导管和电极置放、动物解剖、微透析和激光多普勒超 声探头立体定位。在电生理学领域里，DR. Dean具有丰富的活体电生理数据的仪器测量、记录和分析经验，包括大脑皮层脑电图棘波和癫痫发作活性、脑阻抗、脑近红外光谱(NIRS)、脑部激光多普 勒、温度、ECG、EMG、血压、超声血流量测量以及胎儿呼吸运动。此外，他还掌握系统生理学方面的知识，了解复杂和罕见的心血管和中枢神经系统反应。在 分子学领域中，Dr. Dean掌握多种印迹分析方法、引物设计和序列分析、mRNA和蛋白质提取、RT-PCR及凝胶电泳等技术。他在组织学方面的技能包括脑组织染色和分析以 及成像，对于相关的实验室技巧也具有丰富的经验。Dr. Dean从2007年期开始为Edanz Editing工作，主要编辑化学和神经系统科学领域的文章。

Dr Dean’s PhD thesis was titled “Endogenous Neural Excitation and Inhibition and the Evolution of Preterm Brain Injury.” Dr Dean is presently a post-doctoral research fellow in fields related to neuroscience. He has experience in large animal and fetal surgery techniques, including catheter and electrode placement and animal post-mortem and dissections, as well as in stereotaxic placement of microdialysis and laser Doppler probes. In electrophysiology, Dr Dean is skilled in the instrumentation, recording, and analysis of electrophysiological data in vivo, including cortical EEG spike wave and seizure activity, cerebral impedance, cerebral near-infrared spectroscopy (NIRS), cerebral laser Doppler, temperature, ECG, EMG, blood pressure, ultrasonic blood flow measurement, and fetal breathing movements. He possesses training in systems physiology, as well as an understanding of the complex and unique cardiovascular and central nervous system responses. In molecular fields, Dr Dean covers the various blot analysis techniques, primer design and sequence analysis, mRNA and protein extractions, RT-PCR and gel electrophoresis. Histology including staining and analysis of brain tissue and imaging and the associated laboratory skills are all areas in which Dr Dean has experience. Dr Dean began as an editor for Edanz Editing in 2007, and works in fields related to chemistry and neuroscience.

Dr Leslie曾从事过生物化学和分子生物学研究，主要从事癌症、老化和病毒性疾病的分子生物学研究。2000年，在“日本科学与技术”基金的资助下，于神奈川县癌症研究中心研究所进行干细胞研究。次年，在东京大学进行抗癌化合物研究。随后3年内，在日本理化学研究所从事蛋白质产生与分析。2006年进入制药公司担任协调人和医学撰稿人；2010年加盟理文编辑，任撰稿人和编辑。

Dr Leslie Bestilny’s PhD was in biochemistry and molecular biology. His research focused on the molecular biology of cancer, aging and viral diseases. In 2000 he received a Japan Science and Technology (STA) scholarship to research stem cells at the Kanagawa Cancer Research Center Institute. The following year he performed research of anti-cancer compounds at The University of Tokyo. This was followed by 3 years of protein production and analysis at RIKEN Institute. He joined Pharma Inc. in 2006 as a coordinator and medical writer, and in 2010 began working with the Edanz Group as a writer and editor.

Featured Editor

More than 30 years’ experience as a researcher in the biotechnology industry, with expertise in the molecular genetics and biotechnological applications of bacteriophage, bacteria, yeast and fungi

Zahn拥有30年从事学术和生物技术界研究的经验，专注于噬菌体、细菌、酵母和真菌类的分子遗传学和生物技术应用。在Frederick Blattner实验室完成博士学习后，任布朗大学任博士后研究员，与Dr Arthur Landy合作。之后在洛克菲勒大学任Sackler研究员，与Joshua Lederberg合作研究遗传学和信息学。此外，他还是日本京都RITE分子微生物小组的NEDO工业技术研究员，与Hideaki Yukawa合作研究。目前在旧金山地区生物技术业从事研究。2010年开始为理文编辑工作，担任编辑。

Dr Zahn has 30 years’ experience as a researcher in academia and the biotechnology industry, with expertise in the molecular genetics and biotechnological applications of bacteriophage, bacteria, yeast and fungi. After completing a PhD in the laboratory of Dr Frederick Blattner, he was a postdoctoral fellow at Brown University with Dr Arthur Landy, and then a Sackler Fellow in Molecular Genetics and Informatics with Dr Joshua Lederberg at Rockefeller University. Dr Zahn has also worked as a NEDO Industrial Technology Fellow in the Molecular Microbiology Group at RITE, Kyoto, Japan with Dr Hideaki Yukawa. He currently works in the biotechnology industry in the San Francisco Area. Dr Zahn began working as an editor with the Edanz Group in 2010.

Featured Editor

Neuroendocrinology and tumor biology expert

Dr Cleary是生物医学科学家，专注癌症研究和慢性疾病研究。博士论文题目是“从嗜铬细胞到嗜铬细胞瘤：对交感神经链的探讨”。曾在国家神经疾病和中风研究院（NIH）任博士后研究员，作为首席研究员负责一项转移性肾脏疾病治疗新战略研究的项目。在癌肿瘤生物学和癌症发展起源研究方面积累丰富经验，特别是与von Hippel-Lindau gene抑癌基因突变相关的课题。对卫生政策有浓厚的兴趣，曾在美国国立卫生研究院福格蒂国际中心任研究员。在此期间，参与了多项全球卫生政策项目。在同行评审期刊上发表了大量文章，另外还出版了面向非技术性读者的科技文章。2010年加盟理文，从事编辑工作。

Dr Cleary is a biomedical scientist with a special interest in cancer research and chronic disease. Her doctoral thesis was entitled “From chromaffin cells to phaeochromocytoma: insight into the sympathoadrenal lineage”. Dr Cleary was a Post Doctoral Fellow with the National Institutes of Neurological Disorders and Stroke (NIH), where she was the lead researcher on a project investigating novel strategies for the treatment of metastatic kidney disease. Dr Cleary has an extensive history of research in cancer tumor biology and an interest in the developmental origins of cancer, especially those related to mutations of the von Hippel-Lindau gene. Dr Cleary has an interest in health policy and was a Fellow with the Fogarty International Center at the NIH. During this time she was involved in a number of global health policy projects. Dr Cleary has published a number of articles in peer-reviewed journals in addition to other science writing for a non-technical audience. Dr Cleary began working as an editor for the Edanz Group in 2010.

英国爱丁堡大学药理学研究员、伦敦大学和牛津大学研究助理、阿伯丁大学生理学讲师。在阿伯丁大学，她还建立了电生理实验室，用以研究药物作用与哺乳动物心室肌细胞电活动的关系。Dr Cant拥有丰富的写作和编辑经验，曾为欧共体Cordis Results and Publications数据库和BEST（英国科技专家）数据库及其在美国的姐妹数据库编辑生物和物理科学类文章。多年任Thomson Scientific医学编辑、数据库编索人，拥有心血管病学、肠胃病学、神经科学、流行病学、药理学和生理学领域的知识背景。

Dr Cant has been a Research Fellow (Pharmacology) at the University of Edinburgh and a Research Assistant at the University of London and the University of Oxford, as well as a Lecturer in Physiology at the University of Aberdeen where she also established an electrophysiology laboratory for investigation of drug effects on electrical activity in isolated mammalian cardiac ventricular cells. Dr Cant also has extensive writing and editing experience, having edited papers in biological and physical sciences for the European Community CORDIS Results and Publications databases, as well as for the BEST (British Expertise in Science and Technology) database and its sister database in the US. Dr Cant was a medical editor/database indexer for Thomson Scientific for a number of years and has a wide knowledge of various areas including cardiovascular disease, gastroenterology, neuroscience, epidemiology, pharmacology and physiology.

职业经历

Dr. Lodge 是一名细胞生物学家，在学术研究领域具有广泛的经验，初期从事制药及干细胞疗法监管事务。博士和博士后就读阶段，他主要研究神经系统发育过程中肌动蛋白细胞骨架和细胞黏附分子对轴突导向的作用。Dr. Lodge 于2001年加入葛兰素史克 (GlaxoSmithKline) 公司，领导神经变性疾病和精神疾病的目标识别和确认工作，以及干细胞相关的药物研发战略的开发。2009年至2011年间，Dr Lodge任伦敦大学学院 (University College London) 干细胞疗法项目负责人，负责根据最新颁布的高级治疗要用产品(ATMPs)指令申请相关证照的工作。他具有广泛的细胞生物、分子生物和蛋白质生化技术等方面的专业技能，在国际同行评审期刊上发表过多篇第一作者文章，对于多种临床前及临床规范性文件的写作经验丰富。Dr. Lodge 目前从事基于细胞的药物研究、ATMP监管事务以及学术写作(包括web开发)方面的咨询工作，从2008年起开始为 Edanz Group 工作。

Dr Lodge is a cell biologist with wide-ranging experience in academic research, early stage drug discovery, and stem cell therapy regulatory affairs. For his PhD and postdoctoral work, Dr Lodge studied the roles of the actin cytoskeleton and cell adhesion molecules in axon guidance during nervous system development. Dr Lodge joined GlaxoSmithKline in 2001, where he held research and programme leadership roles within target validation initiatives for neurodegenerative and psychiatric diseases. He was also involved in developing drug discovery strategies involving stem cells. From 2009 to 2011, Dr Lodge was Programme Manager for a stem cell therapy unit at University College London, where he was responsible for the unit obtaining the necessary licenses required by the recently introduced Advanced Therapy Medicinal Products (ATMPs) directive. His technical expertise covers a broad spectrum of cell biology, molecular biology and protein biochemistry techniques, including their application to drug discovery assay development. Dr Lodge has published several first author publications in international peer-reviewed journals, and he is experienced in writing a variety of pre-clinical and clinical regulatory documents. Dr Lodge currently offers consulting services in cell-based drug discovery, ATMP regulatory affairs, and scientific writing (including web development). He began editing for the Edanz Group in 2008.

Featured Editor

Reviewer with numerous peer-reviewed journal publications across the biology field

Taylor拥有15年作为渔业、水产业和资源管理领域研究科学家和顾问的经验。2005–2008年期间，任新西兰卡森研究所科学负责人、后为Biosecurityand Biotechnology工作。曾多次受邀在国际大会和研讨会作特邀发言，曾为一些国际环境管理计划（如国际海事协会）提供建议。曾在多家同行评审期刊上发表文章、撰写客户报告和普通专业文章。此外，还是学术期刊（如Marine Ecology Progress Series）、研究生论文和基金申请书的审稿人。现在澳大利亚昆士兰任水资源顾问，2009年初开始为理文编辑工作。

Dr Taylor has 15 years’ experience as a research scientist and consultant in fisheries, aquaculture and resource management. Dr Taylor was a science leader (2005–2008) at the Cawthron Institute and then Manager Biosecurity and Biotechnology. He has been a guest speaker at several international conferences and workshops and provides advice to international initiatives in environmental management (e.g. International Maritime Association). Dr Taylor has written numerous peer-reviewed journal publications, client reports and general interest articles. He is also a reviewer for academic journals (e.g. Marine Ecology Progress Series), postgraduate theses and grant applications. Dr Taylor works as a water resource consultant in Queensland, Australia, and began working with the Edanz Group in early 2009.

Dr. Daniel 的博士学位论文题为“Molecular Characterization of the Hsp70/Hsp90 Organizing Protein (Hop): Phosphorylation, Subcellular Localization and Interaction with Hsp90”。熟悉各种实验室和研究技巧，包括分子生物学技术、器官培养、永生化细胞系 (哺乳动物) 的组织培养、外源蛋白的重组和纯化、重组DNA、荧光共焦显微术、哺乳动物细胞瞬时转染、定点突变、单/双向凝胶电泳、化验、蛋白质印迹、表面等离子体共 振技术、薄层高压液相色谱法 (HPLC) 等。Dr. Daniel从2008年起加入理文编辑。

Dr Daniel’s PhD thesis was entitled “Molecular Characterization of the Hsp70/Hsp90 Organizing Protein (Hop): Phosphorylation, Subcellular Localization and Interaction with Hsp90.” Dr Daniel is familiar with all standard laboratory and research techniques including molecular biological techniques, organ culture, tissue culture of immortalized cell lines (mammalian), recombinant production and purification of heterologous proteins, recombinant DNA manipulation, confocal fluorescent microscopy, transient transfection of mammalian cells, site directed mutagenesis, one- and two-dimensional gel electrophoresis, assay techniques, Western blot analysis and surface plasmon resonance spectroscopy, and thin layer and high pressure liquid chromatography (HPLC). Dr Daniel began as an editor with the Edanz Group in 2008.

Featured Editor

Experienced ophthalmology researcher: specialized in diabetic retinopathy

Dr Lutze的研究生方向是视觉科学，对因疾病和遗传基因导致的色彩视觉变化进行评估。博士后期间与眼科医生一起工作，拥有眼科临床工作与临床研究的经验。曾与一位研究糖尿病视网膜病变和其他视网膜疾病的眼科医生共同工作。目前在北京一家胃肠病学杂志担任语言编辑，2009年开始在理文编辑任编辑。

Dr Lutze's graduate work was in vision science. Her studies involved the assessment of changes in color vision with disease and the genetic basis of color vision. She worked alongside ophthalmologists during post-doctoral training and has experience with ophthalmological clinical activities and research. She later worked with an ophthalmologist studying diabetic retinopathy and other retinal diseases. Dr Lutze works as a language editor for a gastroenterology journal based in Beijing, China, and began working as an editor with the Edanz Group in 2009.

科技与医学作家，编辑经验涉及广泛的医学和生命科学领域。硕士论文涉及抗微生物制剂的开发，用以防治抗药性细菌。曾执教于North Carolina-Greensboro大学，讲授生物学和微生物学，同时还研究肥胖、炎症、胰岛素抵抗之间的联系。曾与他人合作撰写了7份在同行评审期刊上发表的科技文章以及一篇专书论文。持有生物医学研究生写作证书，是生命科学认证编辑（ELS）。作为编辑，编辑了数以百计的研究文章；作为作家，为药业和生物技术业编写了有关健康与医疗的文章。自2010年起为理文编辑工作，担任编辑。

Ms LaPoint is a science and medical writer-editor with experience in a wide range of medical and life science topics. Her master’s thesis involved the development of antimicrobial agents to prevent and treat antibiotic-resistant bacteria. Ms LaPoint has taught biology and microbiology at the University of North Carolina-Greensboro, where she also conducted research investigating links between obesity, inflammation, and insulin resistance. She has co-authored seven scientific manuscripts published in peer-reviewed journals and one scientific book chapter. Ms LaPoint also has a post-graduate biomedical writing certificate and is a board-certified editor in the life sciences (ELS). As an editor she has edited hundreds of research manuscripts, as a writer she has written about health and medical topics for the pharmaceutical and biotechnology industries. She began working as an editor and writer with the Edanz Group in 2010.

Dr Rogers目前任瑞士日内瓦大学科学交流与写作讲师，此前曾任生物技术行业的一个研究实验室主任一职，专门从事蛋白质组学研究，同时还从事食品行业内的初级材料研究。在巴黎大学从事博士后研究，并作为皇家学会研究员在苏塞克斯大学从事研究。发表的文章内容广泛，是七份生物技术专利的联合撰稿人。于2010年开始在理文担任编辑。

Dr Rogers presently is a lecturer in scientific communication and writing at the University of Geneva, Switzerland. He has previously held research positions as a laboratory head within the biotechnology industry, specializing in proteomics research, and within the food industry, conducting research in primary materials. He completed post-doctoral research within the University of Paris, as a Royal Society Fellow, and at the University of Sussex. He has published widely and is joint author to seven biotechnology patents. Dr Rogers began working as an editor for the Edanz Group in 2010.

Featured Editor

Biomedical engineering, microtechnology and electronics specialist

Frew先生现为加拿大British Columbia大学电子和计算机工程系应用科学专业硕士研究生，研究领域包括：医学图像处理和超声波换能器、以及在医学诊断和前列腺近距离放射治疗中的应用。之前曾在惠灵顿维多利亚大学工作，担任研究助理，曾在Fisher & Paykel Healthcare公司工作两年半，从事于阻塞性睡眠呼吸中止症治疗仪器的开发。在多个领域拥有丰富经验：包括生物医学工程、微技术、电子学和风险管理。2009年初开始为理文编辑工作。

Mr Frew is presently a Master of Applied Science candidate in the Electrical & Computer Engineering Department of the University of British Columbia, Canada. His research interests include medical image processing and ultrasonic transducer hardware, with applications to medical diagnosis and prostate brachytherapy. Previously, Mr Frew worked at Victoria University of Wellington as a research assistant and spent two and a half years at Fisher & Paykel Healthcare, developing medical devices for the treatment of obstructive sleep apnea. He has experience in a diverse range of topics, including biomedical engineering, microtechnology, electronics and risk management. Mr Frew began working with the Edanz Group in early 2009.

Hackett女士从事科学期刊编辑工作15年，最初在Elsevier Science出版公司旗下的Current Science期刊从事科学出版工作，。1997至2007年间，在极具影响力的评审期刊Current Opinion in Structural Biology独挑管理与编辑大梁。2002年，出任Current Opinion生命科学评审期刊选集责任编辑，在Elsevier药物发现小组内部组织评审期刊精选活动。在出版公司担任编辑期间，还曾为Trends in Biochemical Science、Trends in Pharmacological Science、Trends in Cell Biology、International Journal of Infectious Diseases、Development和Drug Discovery Today担任文章编辑。现为全职撰稿人和编辑顾问。于2009年开始为理文编辑工作，担任编辑。

Ms Hackett has been a science journal editor for 15 years, beginning her science publishing career in the Current Science group, which became part of Elsevier Science. Between 1997 and 2007, she had sole responsibility for managing and editing the high-impact review journal Current Opinion in Structural Biology. In 2002, Ms Hackett became Managing Editor of the portfolio of Current Opinion life science review journals and helped launch a collection of review journals within Elsevier’s Drug Discovery group. During her publishing career as an editor, Ms Hackett has edited articles for Trends in Biochemical Science, Trends in Pharmacological Science, Trends in Cell Biology, the International Journal of Infectious Diseases, Development, and Drug Discovery Today. She now works as a full-time publishing and editorial consultant. Ms Hackett began working as an editor for the Edanz Group in 2009.

Dr Barnett的博士论文题目是“妊娠期和哺乳期母体蛋白质摄入量的变化对后代脂代谢的影响 – 大鼠试验研究”，研究了早期营养对胰腺功能和胰岛素代谢的影响。博士后课题内容是利用“组学”技术（如：微阵列技术和蛋白质组学）在小鼠模型上研究ω- 3和ω-6脂肪酸对肠道炎症的作用。目前任新西兰AgResearch研究机构的高级研究科学家，最近的工作领域是表观遗传学（主要是DNA甲基化）。Dr Barnett已发表了20篇同行评审期刊文章（自2010年以来共有11篇），参与编写了一篇同行评审专书论文，并曾在一些国际会议上受邀演讲。Dr Barnett于2011年加入理文编辑，主要从事生理学、基因组学/蛋白质组学/代谢组学、表观遗传学与肠道炎症和免疫等领域的编辑工作。

Dr Barnett’s PhD thesis, "Effect of variation in maternal protein intake during gestation and lactation on fuel metabolism in the offspring - studies in the rat", investigated the effects of early nutrition on pancreatic function and insulin metabolism. Dr Barnett post-doctoral studies investigated the role of omega-3 and omega-6 fatty acids on intestinal inflammation in a mouse model using 'omics' technologies such as microarrays and proteomics. He is currently a Senior Research Scientist working for AgResearch in New Zealand; recently working in the field of epigenetics, in particular DNA methylation. Dr Barnett has published 20 peer-reviewed journal articles (11 since 2010) and one peer-reviewed book chapter, and has been an invited speaker at a number of international conferences. Dr Barnett joined the Edanz Group as an editor in 2011 with editing expertise in physiology, genomics/proteomics/metabolomics, epigenetics and intestinal inflammation and immunity.

Ms Davis曾在美国、德国和丹麦的几所学术机构从事生物化学和分子生物学的研究与开发。过去20年里，曾受聘于加州几家生物技术企业，从事酵母异质基因表达和诊断方法的开发，负责实验室管理。此期间，还负责科学论文和生物技术的商业文件的编辑。2010年加盟理文编辑。

Ms Davis has worked in research and development in the areas of biochemistry and molecular biology at several academic institutions in the U.S., Germany, and Denmark. For the last 20 years, she has been employed in biotechnology companies in California where she was involved in heterologous gene expression in yeast and diagnostic assay development as well as laboratory operations. During this time, she was also responsible for editing scientific articles and biotech business documents. She joined the Edanz Group in 2010.

Dr Wilhelmi博士研究课题为受污染矿废水重金属的生物修复。之后进入掺杂控制研发实验室，从事皮质激素类检测免疫法研究。重返学术界后，一直从事各生物化学领域的研究，包括P450药物代谢、DNA条形码、连续发酵和生物修复。目前开展的研究包括：肝微粒体的分离、克隆、P450对碘氧基苯甲醚的表现和特性。该研究的目的是确定各种新型复合物和药物滥用的新陈代谢。另一个研究领域是：利用DNA标志物确定南非禁猎区稀有危险食草动物习性的可能性，尤其研究了rbcL基因作为这些食草动物之食物的生物标志物。Dr Wilhelmi是罗德斯大学的一名高级讲师，教授的课程包括：新陈代谢、分析法和法医生物化学。曾多次出席色谱法和分析生物化学、保护生物化学和酶学的学术会议并发表多篇论文。2012年加盟理文，担任编辑。

For his PhD, Dr Wilhelmi researched the bioremediation of heavy metals from contaminated mine waste waters. He then worked in a doping control Research and Development laboratory investigating immunological techniques for the detection of corticosteroids. On returning to academia his research has been in a number of biochemical fields, including P450 drug metabolism, DNA barcoding, continuous fermentation and bioremediation. His current research involves the isolation of liver microsomes, cloning, expression and characterization of P450 isoforms. This research is aimed at determining the metabolism of various novel compounds and drugs of abuse. A second research interest investigates the potential of using DNA markers for determining the diet of elusive and dangerous herbivores on South African game reserves. In particular the work has investigated the rbcL gene as a biomarker for plants consumed by these herbivores. Dr Wilhelmi is a senior lecturer at Rhodes University, where he teaches metabolism, analytical techniques and forensic biochemistry. He has presented at conferences and has published in the areas of chromatography and analytical biochemistry, conservation biochemistry, and enzymology. Dr Wilhelmi joined the Edanz Group as an editor in 2012.

Featured Editor

Edited more than 3,000 manuscripts for Japanese authors

Dr Sherwin的专业背景是生物化学，主攻骨关节炎、组织工程和细胞培养。积累了细胞和分子生物学技术方面的大量经验，写作经验丰富，在英国和新西兰博士后工作期间，作为第一作者和辅助作者发表了大量同行评审期刊文章和科学报告。2002年起成为理文编辑的全职编辑，已为日本作者编辑了3000多篇用于研究领域的文章和有关生命与健康的期刊投稿。

Dr Sherwin’s scientific background is in biochemistry with an emphasis on osteoarthritis, tissue engineering and cell culture. She has wide experience in both cell and molecular biology techniques. Dr Sherwin has excellent writing skills and has published several peer-reviewed journal articles and scientific reports as both lead author and supporting author during her post-doctoral work in the United Kingdom and New Zealand. Dr Sherwin has been a full-time editor with Edanz Editing since 2002. During that time, she has edited over 3000 manuscripts in the Health and Life Sciences for Japanese and Chinese authors, with a wide range of research fields and target journals.

Dr Ambrose的微生物学博士课题是：细菌中易错（突变后代）跨损伤DNA合成途径的转录调节研究。博士后研究分别在哈佛大学/麻省理工学院和加州大学洛杉矶分校进行，主要研究酵母和人体模型系统内的DNA修复和诱变。最近一直担任新西兰奥克兰大学生物科学讲师。已发表数篇同行评审文章，多次出席国家级和国际级学术会议。2011年加入理文编辑。

Dr Ambrose’s PhD in microbiology investigated the transcriptional regulation of error-prone (mutation generation) translesion DNA synthesis pathways in bacteria. His postdoctoral research at Harvard University/Massachusetts Institute of Technology and at the University of California, Los Angeles, focused on the regulation of DNA repair and mutagenesis in yeast and human model systems. Dr Ambrose has recently been a lecturer (Biological Sciences) at the University of Auckland, New Zealand. He has several peer-reviewed publications, and has presented at national and international scientific meetings. He joined the Edanz Group as an editor in 2011.

Dr Ao 已完成生物化学与分子生物学博士学位研究，研究的主要内容是癌症生物学和抗雌激素治疗耐受性。目前任范德比尔特大学博士后研究员，在再生化学生物学交叉学科领域开展研究。曾创作并发表了同行评审查文章、评论文章以及科普专书论文，内容包括：表观遗传学对癌症生物学的影响、再生医学中的化学生物学、以及癌症干细胞在抗雌激素治疗耐受性中的作用等。2011年加盟理文编辑，担任编辑工作。

Dr Ao completed her PhD studies in Biochemistry and Molecular Biology, with a focus on cancer biology and anti-estrogen therapy resistance. She is currently a postdoctoral fellow at Vanderbilt University, conducting research in the interdisciplinary field of regenerative chemical biology. She has composed and published a number of peer-reviewed articles, a review article, and a book chapter for a broader scientific audience. The topics ranged from the influence of epigenetics on cancer biology, chemical biology in regenerative medicine, and the role of cancer stem cells in anti-estrogen therapy resistance. Dr Ao joined the Edanz Group as an editor in 2011.

Featured Editor

Expert in models and diagnosis of Parkinson's disease

Tinsley拥有南澳弗林得斯大学医学院博士学位。研究课题为“非病毒神经胶质细胞传染：中枢神经系统再生治疗战略”。博士后工作期间，在首位证明成年人大脑中神经形成的专家Peter Eriksson教授的神经干细胞实验室工作。之后重返澳大利亚，在霍华德•弗利研究所工作，研究帕金森氏疾病的模型和诊断。拥有十多年医学研究经验，曾在知名专业期刊发表作品，包括Annals of Neurology。2011年起为理文编辑工作，担任编辑。

Dr Tinsley completed his PhD at the School of Medicine at Flinders University of South Australia. His thesis title was "Non-Viral Glial Cell Transfection: A Therapeutic Strategy for CNS Regeneration." His post-doctoral training was in the neural stem cell laboratory of Prof Peter Eriksson, the first to demonstrate neurogenesis in the adult human brain. Dr Tinsley returned to Australia to work at the Howard Florey Institute, investigating models and diagnosis of Parkinson's disease. He has over ten years experience in medical research, and has published widely in leading journals in his field, including Annals of Neurology. Dr Tinsley began working as an editor with the Edanz Group in 2011.

美国堪萨斯州曼哈顿岛堪萨斯州立大学知名名誉退休教授。在眼睛细胞生物和蛋白质化学领域拥有丰富经验，从事相关研究长达30余年。其研究长期以来得到了美国国立卫生研究院的资金支持。一直为多个国家和国际委员会从事视觉研究，其中包括国家眼科研究所科学顾问委员会、Lens & Cataract Panel of the National Eye Institute、视觉与眼科学研究理事委员会等。Takemoto教授出生于美国，祖籍日本，曾作为日本学术振兴会研究员广泛开展研究和考察活动。在同行评审期刊上发表了150余篇作品，于2011年加入理文，担任编辑。

Prof Takemoto is a University Distinguished Professor Emeritus at Kansas State University, Manhattan, KS, USA. He has extensive experience in the cell biology and protein chemistry of the eye, which he has studied for over 30 years. His research has been continuously funded by the National Institutes of Health of the US. He has served on numerous national and international boards dealing with vision research, including the Board of Scientific Counselors of the National Eye Institute, Lens & Cataract Panel of the National Eye Institute, and the Board of Directors of the Association for Research in Vision & Ophthalmology (ARVO). Prof Takemoto, though US-born, traces his ancestry back to Japan and has conducted research and traveled extensively in Japan as a Fellow of the Japan Society for the Promotion of Science. He has published over 150 peer-reviewed manuscripts, and joined the Edanz Group as an editor in 2011.

Milazzo先生自康奈尔大学毕业后，在一家临床前合同研究组织工作了10年，在那里负责一系列面向生物技术、制药和医疗器械企业的跨学科项目。后来在一家从事开发眼科、骨科、心血管用控释药物植入的生物技术公司任临床前研究主任，参与了多项向美国FDA提交的IND和NDA应用项目。后去新西兰攻读博士学位，曾与多家从事开发肽治疗肌肉萎缩疾病和癌症检测与监测分子诊断产品的生物技术企业合作。2010年提交了博士论文，题为“羊脂的发现 —  对皮下脂肪间充质干细胞和髌下脂肪间充质干细胞进行羊模型软骨缺损修复软骨能力方面的比较”。Milazzo先生的实验室经验涵盖了各种大型和小型研究动物模型的技术和手术技巧（尤其是骨科），其中包括：干细胞和软骨细胞的分离和培养、免疫组织化学、生化分析、组织病理标本制备与评估、显微镜技术、RNA提取和cDNA制备、基因芯片等。2011年加盟理文编辑，担任编辑。

After graduation from Cornell University, Mr Milazzo worked for 10 years at a preclinical contract research organization where he was in charge of multi-disciplinary programs for biotechnology, pharmaceutical and medical device companies. Later Mr Milazzo became the director of preclinical research for a biotechnology company developing controlled-release drug implants for ophthalmic, orthopedic, and cardiovascular use, contributing to several IND and NDA applications to the US FDA. Mr Milazzo moved to New Zealand for his PhD studies, and has been working with biotechnology companies developing peptide therapies for muscle wasting disease and molecular diagnostic products for cancer detection and monitoring. His PhD thesis submitted in 2010, was entitled "Sheep Fat Bingo - A Comparison of Subcutaneous Adipose-Derived Mesenchymal Stem Cells with Infrapatellar Adipose-Derived Mesenchymal Stem Cells with Regard to their Chondrogenic Ability in a Sheep Model of Osteochondral Defect Repair". Mr Milazzo’s laboratory expertise includes techniques and surgical skills (particularly orthopedic) associated with a variety of large and small research animal models. These include stem cell and chondrocyte isolation and culture, immunohistochemistry, biochemical assay, histopathology specimen preparation and evaluation, microscopy, RNA extraction and cDNA preparation, and gene microarray. Mr Milazzo joined the Edanz Group as an editor in 2011.

Dr Eager目前是美国德克萨斯州达拉斯的一名住院部医师。在过去10年里，已积累了丰富的临床研究和临床前研究经验，重点是肿瘤学领域。曾任玛丽克劳利癌症研究中心机构审查委员会成员6年，在此期间，审阅了大批I阶段到III阶段临床试验协议。除临床经验外，Dr Eager 还在体外临床前协议与技术、细胞培养和组织学方法等领域拥有丰富经验，拥有广博的微生物技术知识。Dr Eager撰写并合作撰写了8份出版物，起草了4份临床/临床前研究协议。Dr Eager去年一直兼职科技稿件专业编辑，2011年起加盟理文编辑，担任编辑。

Dr Eager currently practices internal medicine as a hospitalist in Dallas, Texas, USA. Over the past decade he has amassed considerable experience in clinical and pre-clinical research, principally in the field of oncology. He was a member of the Mary Crowley Cancer Research Center Institutional Review Board for six years, during which time he reviewed numerous Phase I through Phase III clinical protocols. In addition to his clinical expertise, Dr Eager has experience with in-vitro pre-clinical protocols and techniques as well as cell culture, histological methods, and animal model studies, and is skilled in a wide range of microbiology techniques. Dr Eager has authored and co-authored eight publications, and has authored four clinical or pre-clinical protocols. On a part-time basis, Dr Eager has edited scientific manuscripts professionally for the past year and began editing for the Edanz Group in 2011.

Sharman的博士学位是在Peter Holland实验室完成的，研究重点是脊椎动物早期进化中的同源盒基因倍增。博士后期间与Michael Brand一起开展“斑马鱼神经系统发育”研究；期间以第一作者身份发表了三篇论文和三篇评审文章。之后开始从事期刊编辑工作。曾任Trends in Biochemical Sciences编辑、Current Biology助理编辑和Genome Biology高级编辑。拥有7年专职编辑经验，了解期刊作品发表和同行评审要求。2010年获“编辑与校对协会高级会员”资格，擅长生物和医学文章编辑；特别是关于进化、发育生物学和基因学作品的编辑。自2011年起为理文编辑工作。

Dr Sharman's PhD, in the lab of Peter Holland, focused on homeobox gene duplication in early vertebrate evolution. Her post-doctoral work was with Michael Brand on zebrafish neural development; during which she published three first-author papers and three reviews. Dr Sharman then moved into journal editing. She was Editor of Trends in Biochemical Sciences, Assistant Editor of Current Biology and then Senior Editor of Genome Biology. With seven years experience as an in-house journal editor Dr Sharman understands journal publishing and what peer reviewers require in a manuscript. Dr Sharman attained Advanced Member status of the Society for Editors and Proofreaders in 2010 and edits in all areas of biology and medicine; particularly manuscripts on evolution, developmental biology and genomics. Dr Sharman began editing for the Edanz Group in 2011.

Dr Roberts拥有多个领域的大量研究经验。博士研究课题是：结合采用光镊和电脉细胞，测量非水胶体系统中的有效电荷。完成博士学习后，曾在澳大利亚布里斯班的昆士兰大学生物工程与纳米技术研究所（AIBN）以博士后研究员的身份工作两年。研究中采用可调纳米孔来检测纳米粒的生物改性，从而开发出一种简单、易用的生物活性测定技术。Dr Roberts现为泰国清迈大学材料科学研究中心博士后研究员，致力于纳米技术研究，以建立起强大的碳纳米管网络。2011年加盟理文，担任撰搞人和编辑。

Dr Roberts has experience in a wide range of research fields. His PhD research focused on measuring effective charges in nonaqueous colloidal systems using optical tweezers in combination with an electrophoretic cell. After completing his PhD, he worked for two years as a postdoctoral research fellow at the AIBN, in the University of Queensland in Brisbane, Australia. His research used tunable nanopores to detect the biomodification of nanoparticles, aiming to develop a simple, easily applied bioassay technique. Dr Roberts is currently a postdoctoral research fellow in the Materials Science Research Centre at Chiang Mai University, Thailand. He works in the area of nanotechnology attempting to create stronger carbon nanotube networks. Dr Roberts joined the Edanz Group as an editor in 2011.

Pishief先生，出庭大律师、法律编辑和撰稿人，曾编写过很多文字书籍、法律公告，并为多家全球法律平台撰写在线稿件。Pishief先生既拥有法律背景，又拥有科学知识，他在生物医学科学领域的研究重点是分子病理学，尤其是大脑、心脏、肝、肾、骨骼、血液、淋巴系统的病理学（包括组织学）；基因（包括测序、生物信息学和遗传病）；生物医学实验室技术（重点是DNA/ RNA的提取与隔离、反转录、PCR技术和凝胶电泳）；代谢；免疫学；医学微生物学和生理学（包括神经生理学和神经影像学）。是一位经验丰富的报告与摘要写手。2011年起加入理文编辑。

Mr Pishief, a barrister and solicitor, is a legal editor and writer of manuscripts for publication in text books, legal bulletins, and online on global legal platforms. His background in both law and science, with his biomedical science study focusing on molecular pathology, specifcally pathology (including histology) of the brain, heart, liver, kidney, bone, blood, and lymphoid system; genetics, including sequencing, bioinformatics and genetic disorders; biomedical laboratory techniques, with a focus on DNA/RNA extraction and isolation, reverse transcription, PCR, and gel electrophoresis; metabolism; immunology; medical microbiology; and physiology (including neurophysiology and neuroimaging). An experienced report and abstract writer, Mr Pishief joined the Edanz Group as an editor in 2011.

专业背景为生物力学，重点研究退化性关节炎和关节负荷。攻读博士期间，研究使用各种足矫形器后的运动机理，论文获 “Chancellors' Gold Medal”金奖。在斯坦福大学博士后研究期间，主要研究骨关节炎形成和发展过程中的力学及生物学因素。现为新西兰 Otago大学兼职高级研究员，专业技能包括运动分析、逆动力学、力测量、肌电描记术、压力测量、磁共振成像和蛋白质印记法。撰写了大量同行评审期刊文章，为多家杂志担任审稿人，在医学写作方面拥有丰富经验，涉及广泛领域，包括运动科学、风湿病学、整形外科、生物医学工程、生物力学、肥胖症、康复、物理疗法和运动损伤。2008年开始加入理文编辑。

Dr Mündermann’s scientific background is biomechanics with an emphasis on degenerative joint disease and joint loading. For her PhD, she investigated mechanics of running with different types of foot orthoses and received the Chancellors' Gold Medal for her dissertation. As a Post-doctoral Fellow at Stanford University, she focused on mechanical and biological factors in the initiation and progression of osteoarthritis. Dr Mündermann is currently a part-time Senior Research Fellow at the University of Otago, New Zealand. Dr Mündermann's technical skills include motion analysis, inverse dynamics, force measurements, electromyography, pressure measurements, MR imaging and Western blots. She has written numerous peer-reviewed journal articles, acted as a reviewer for several journals and has experience in medical writing in a wide range of topics including sport science, rheumatology, orthopedics, biomedical engineering, biomechanics, obesity, rehabilitation, physiotherapy and sport injuries. Dr Mündermann began working with the Edanz Group in 2008.

分子病毒学家，专注于动物保健。在皇家兽医学院攻读兽医病毒学博士学位时的研究课题是，“牛病毒性腹泻病毒的遗传变异和细胞嗜性”。Dr Desport在莫道克大学完成的博士后研究课题是：重组蛋白疫苗的培育和试验，以控制巴里牛患Jembrana的病情。掌握的技能和方法包括：病毒细胞培养和净化；实时RT/PCR；克隆；DNA排序与分析；DNA/RNA提取与操作；重组蛋白在原核生物系统中的表现和净化；ELISA的培育和优化；原位杂交；抑制免疫；组织病理学和肽地图绘制。曾以第一作者身份发表8篇期刊文章，多次出席国家级和国际级学术会议。现为多家国际期刊的受邀评审员，最近曾为“慢病毒和巨噬细胞：分子和细胞相互作用”一书担任编辑。2011年加盟理文，担任编辑。

Dr Desport is a molecular virologist with interests in animal health. Her thesis for her PhD in Veterinary Virology from the Royal Veterinary College was entitled “Genomic Variation and Cell Tropism of Bovine Viral Diarrhea Virus”. Dr Desport post-doctoral position at Murdoch University focused on the development and testing of a recombinant protein vaccine to control Jembrana disease in Bali cattle. Skills and techniques include cell culture and purification of viruses; Real-Time RT/PCR; cloning; DNA sequencing and analysis; DNA/RNA manipulation and isolation; expression and purification of recombinant proteins in prokaryotic systems; development and optimization of ELISAs; in situ hybridization; immunostaining; histopathology and peptide mapping. Dr Desport has published eight first-author journal articles and has presented at several national and international conferences. She is an invited reviewer for a number of international journals and has recently edited a book entitled “Lentiviruses and Macrophages: Molecular and Cellular Interactions”. Dr Desport joined the Edanz Group as an editor in 2011.

Brown博士研究侧重于调查废水处理中的微生物生态和功能基因组学。研究领域是培养微生物学和分子微生物学技术，包括关键细菌种的针对性隔离、全基因组排序和16S基因繁殖库与荧光原位杂交，以确定和监测细菌群落。开始博士研究之前，Brown女士专注于分子技术的研究，调查多元化环境中的微生物群落，包括南极土壤、冰下沉积物和哺乳动物胃肠道。Brown女士现为奥克兰大学的一名生物学助教，撰写过多篇研究论文。于2011年加盟理文编辑，担任编辑。

Ms Brown’s PhD research focused on investigating the microbial ecology and functional genomics of wastewater treatment. This research involved both culture-based and molecular microbiology techniques including targeted isolation of key bacterial species, whole-genome sequencing and both 16S gene clone libraries and fluorescence in situ hybridization for identification and monitoring of bacterial communities. Prior to her PhD Ms Brown specialized in the use of molecular techniques for investigating microbial communities in diverse environments, including Antarctic soils, subglacial sediments and the mammalian gut. Ms Brown is currently employed by the University of Auckland as a biology tutor and writer of research papers. She joined the Edanz Group as an editor in 2011.

Dr Donkin的博士论文题目是“神经肽P物质对大鼠创伤性脑损伤后果的作用”。研究兴趣还包括利用啮齿动物模型开发用于治疗脑外伤和神经退行性疾病的新药物治疗剂。已完成在加拿大不列颠哥伦比亚大学的博士后研究，研究在预防和治疗阿尔茨海默氏病中采用防治化合物的可能性。Dr Donkin已发表多篇同行评审期刊文章，目前的职业是科研作家。2011年加入理文，担任科技编辑、撰稿人和审稿人。

Dr Donkin's PhD thesis was entitled "The Effects of the Neuropeptide Substance P on Outcome Following Traumatic Brain Injury in Rats". His research interests include developing novel pharmacotherapeutic agents for the treatment of neurotrauma and neurodegeneration using rodent animal models. He has completed a post-doctoral fellowship at the University of British Columbia, Canada, investigating potential prophylactic and therapeutic compounds in the prevention and treatment of Alzheimer's disease. Dr Donkin has published several peer-reviewed journal articles and currently works as a scientific writer. Dr Donkin joined the Edanz Group as a science editor, writer and reviewer in 2011.

Bass女士是一名医学学术和临床研究撰稿人、编辑。自2007年起一直从事研究基金申请书撰写、书稿编辑工作，并担任加州大学圣迭戈分校实验室的项目经理，协助多个领域的研究者进行研究，其中包括：医院政策和质量改进、放射学、医用物理学、纳米技术、材料科学和基因组学等不同领域。Bass女士还编辑了一些有关病人教育和补充/替代医疗的指导手册，并担任圣地亚哥一家健康保险公司的新闻稿件编辑工作。除了学术学位以外，Bass女士还于2004年获得圣迭戈州立大学科技写作高级证书。2011年加盟理文编辑，担任编辑。

Ms Bass is a science writer and editor focused on academic medicine and clinical research. Since 2007, she has served as a grant writer, manuscript editor, and project manager for many UC San Diego laboratories, assisting investigators involved in such diverse fields as hospital policy and quality improvement, radiology, medical physics, nanotechnology, materials science, and genomics. Ms Bass has also edited patient-education and complementary/alternative medicine guidebooks and newsletters for a San Diego-based health insurer. In addition to her academic degrees, in 2004 Ms Bass earned an Advanced Certificate in Technical & Scientific Writing from San Diego State University. Ms Bass joined the Edanz Group as an editor in 2011.

博士学习期间研究神经解剖学和神经药理学，主要涉及神经退化性疾病中氧化应激的作用。研究过程中，曾对促氧化酶、髓过氧物酶、死后脑组织和神经原纤维病理中细胞模型的表达和活动情况进行调查。曾在国际同行审查期刊杂志上发表过两篇论文，现为新西兰Otago大学人类生物学讲师。2010年开始为理文编辑工作，担任编辑。

Dr Byrne’s PhD studies in neuroanatomy and neuropharmacology have centered on the role of oxidative stress in neurodegenerative diseases. In her research she investigated the expression and activity of the pro-oxidant enzyme, myeloperoxidase, in post-mortem human brain tissue and in cellular models of neurofibrillary pathology. She has published two papers in international peer-reviewed journals and is currently a teaching fellow in human biology at the University of Otago, New Zealand. She began working as an editor for the Edanz Group in 2010.

曾任美国新墨西哥阿尔伯克基市桑迪亚国家实验室的一名专业研究员长达31年。最初从事气相激光光谱学研究以及将之应用到量子检测过渡金属表面吸附的分子。在潜心研究电子跃迁感应解吸附多年后，开始关注界面摩擦学，研究新型扫描探针法下的分子摩擦以及研究共轭聚合物界面摩擦。在最近的几年研究中，与新墨西哥大学病理学科合作，利用原子力显微镜与荧光成像技术，对细胞膜中信号发送域的结构性特点进行研究。2011年加盟理文，担任编辑。

Dr Burns was a staff scientist at Sandia National Laboratories in Albuquerque, New Mexico, USA, for 31 years. His career began with gas phase laser spectroscopy with applications to quantum-resolved detection of molecules desorbed from transition metal surfaces. After many years of research in the field of desorption induced by electronic transitions, he began to focus on interfacial tribology and investigated the molecular-level aspects of friction with novel scanning probe techniques and conjugated polymer interfaces. During his final years of active research, he collaborated with the Dept. of Pathology at the University of New Mexico on the structural characterization of signaling domains in cellular membranes using combined atomic force microscopy and fluorescence imaging. Dr Burns joined the Edanz Group as an editor in 2011.

Featured Editor

Stem cell specialist

Arico先生过去几年里一直在澳大利亚科技界工作学习，在一些国际公认组织内从事研究工作（如昆士兰与加尔文医学研究所）。这一期间，他的研究主要集中在肿瘤免疫治疗和免疫学方面。Arico 先生还有在私营生物技术公司（分子诊断领域）的工作经历。2006年在莫纳什大学知名教授的指导下，完成了人类胚胎干细胞不可逆胚层分化的研究，获得了荣誉学位。擅长领域：细胞培养（包括人类和小鼠胚胎干细胞），利用胚胎干细胞和成年干细胞进行体外细胞分化，各种成像技术，细胞化验，流式细胞仪，细胞提纯技术，PCR，克隆，转染等。对组织工程技术、干细胞临床应用有着浓厚的兴趣。2011年开始为理文编辑工作，担任编辑。

Mr Arico has been working and studying in the Australian scientific sector for the past several years and has held research positions at internationally recognized organizations such as the Queensland and Garvan Institutes of Medical Research. During this time his research focused on Cancer Immunotherapy and Immunology. Mr Arico has also worked in the private biotechnology sector in the area of Molecular Diagnostics. Mr Arico completed his honors degree in 2006 under the direction of a prominent Professor of Stem Cell Sciences at Monash University researching definitive endoderm differentiation from human embryonic stem cells. His technical skills include: cell culture including human and mouse embryonic stem cells, in vitro cell differentiations using embryonic and adult stem cells, various imaging techniques, cell-based assays, flow cytometry, cell purification techniques, PCR, cloning and retroviral transfections. Mr Arico has a strong interest in tissue engineering technologies and the clinical use of stem cells. He began working as an editor with the Edanz Group in 2011.

Dr Hitchin，有机合成化学家，拥有8年多制药和精细化工行业经验，精于合成化学、药物化学和工艺研究与开发。博士学位的研究课题是多官能基化奎宁环的合成与应用。目前任职于英国癌症研究中心高级科学主任，该中心设于英国百德新癌症研究所，在那里他带领一组药物化学专家研究肿瘤药物的新靶点。Dr Hitchin还曾任肯特郡 Sandwich实验室辉瑞全球研究与开发项目的化学组组长，负责设计和实施所有治疗方面的综合战略（包括疼痛、肥胖和病毒学），取得了很大成功。此外，还曾在一家由美国FDA批准工厂从事C – GMP生产。已在同行评审期刊上发表过多篇文章。2011年加盟理文编辑，担任编辑。

Dr Hitchin is a synthetic organic chemist with over eight years of experience in the pharmaceutical and fine chemical industries. He is skilled in the areas of synthetic chemistry, medicinal chemistry and process research and development. Dr Hitchin’s PhD investigated the synthesis and application of poly-functionalized quinuclidine systems. He is currently a Senior Scientific Officer for Cancer Research UK at the Paterson Institute of Cancer Research in the UK, where he leads a team of medicinal chemists investigating novel drug discovery targets in oncology. Dr Hitchin has also worked as a Chemistry Group Leader for Pfizer Global Research and Development at the Sandwich laboratories in Kent, UK, where he was responsible for the successful design and implementation of synthetic strategies across therapeutic areas including pain, obesity and virology. Further to this, Dr Hitchin has worked providing c-GMP manufacture in an FDA approved facility. Dr Hitchin has published in several peer-reviewed journals. He joined the Edanz Group as an editor in 2011.

Igelstrom 女士现任奥塔哥大学电生理学研究人员，拥有生物化学和生理学专业背景，现从事神经科学专业。她的博士研究内容主要是癫痫发作的脑片模型，目前正在研究抗癫痫药物治疗中采用的离子通道调制剂。在电生理技术领域经验丰富，其中包括全细胞电压/电流钳，细胞贴附式密封电流钳，场电位记录，单细胞电位记录等。以往和目前的研究范围：行为激励制约，嗅觉处理，非突触神经递质，癫痫发作，抗癫痫药物，抗抑郁药物等。Igelstrom女士还对替代疗法/补充疗法的生理作用有着浓厚的兴趣，如中医和瑜伽。除了在电生理学领域的经验外，Igelstrom女士还拥有细胞培养、免疫印迹、显微镜技术、大鼠行为训练和免疫组化等方面的经验。Igelstrom 女士2011年加盟理文编辑，担任编辑。

Ms Igelstrom currently works as an electrophysiologist at the University of Otago. She has a background in biochemistry and physiology, and is now specializing in neuroscience. Her PhD research focused on brain slice models of epileptic seizures, and she is currently investigating ion channel modulators for antiepileptic drug treatment. She has experience with a variety of electrophysiological techniques, including whole-cell voltage/current clamp, cell-attached tight-seal current clamp, field potential recording, and single-unit recording. Her past and current research interests include behavioral reward conditioning, olfactory processing, non-synaptic neurotransmission, epileptic seizures, antiepileptic drugs, and antidepressant drugs. Ms Igelstrom also has a special interest in the physiological effects of alternative and complementary therapies, such as Chinese medicine and yoga. Apart from her electrophysiological skills, Ms Igelstrom also has experience with cell culture, western blotting, microscopy, behavioral rat training, and immunohistochemistry. Ms Igelstrom joined the Edanz Group as an editor in 2011.

Featured Editor

Expert in the molecular genetics of psychiatric illness

Patel是一名神经科学家，专注于中枢神经系统退化和精神疾病的研究。在博士课题下，他开发了一个小鼠基因剔除模型，用于人类脑神经紊乱失调铜蓝蛋白缺乏症的研究。之后在哈佛大学医学院细胞生物学系担任研究员，研究神经细胞迁移中的分子信号通路。Patel近期一直在蒙特利尔道格拉式心理健康研究所担任助理，专注于精神疾病分子基因的研究。研究重点是严重抑郁症和自杀中的 microRNA信号网络microRNA的信令网络参与严重抑郁症和自杀。以第一作者的身份在很多有影响力的期刊上发表了多篇文章，包括《生物化学期刊》和《神经科学期刊》。2011年开始在理文编辑从事编辑工作。

Dr Patel is a neuroscientist interested in central nervous system degeneration and mental illness. For his doctoral thesis he developed a mouse gene-knockout model for the human neurological disorder aceruloplasminemia. Subsequently, as a research fellow at the Department of Cell Biology at Harvard Medical School he studied the molecular signaling cascades involved in nerve cell migration. Dr Patel has recently focused his research on the molecular genetics of psychiatric illness as an associate at the Douglas Mental Health Institute in Montreal. His studies center on microRNA signaling networks involved in major depression and suicide. Dr Patel has published a number of first-author articles in high-impact journals, including The Journal of Biological Chemistry and The Journal of Neuroscience. He began editing for the Edanz Group in 2011.

Dr Finnie是一名干细胞生物学家。博士研究课题为脐带血中干细胞种群的判定和隔离，以及在骨骼和软骨组织工程中应用的可能性。之前曾任英国施乐辉研究中心高级博士后研究员，工作在研究和开发第一线，从事成人干细胞治疗在再生医学（即骨置换和骨关节炎）中商业化应用研究。曾在国际同行评审期刊中发表研究成果。现任多个生物领域的撰稿人和编辑、欧洲医学作家协会（EMWA）会员。2011年9月加入理文编辑。

Dr Finnie is a stem cell biologist whose PhD research led to the identification and isolation of rare stem cell populations within umbilical cord blood, with the potential for bone and cartilage tissue engineering applications. Dr Finnie was then a senior Postdoctoral Research Scientist at Smith & Nephew's research center in the UK, where she worked at the forefront of both research and development stages to commercialize adult stem cell therapies for regenerative medicine, namely bone replacement and Osteoarthritis. Dr Finnie has published her research in international peer-reviewed journals. She is currently a science writer and editor across diverse biological areas and is a member of the European Medical Writers Association (EMWA). Dr Finnie joined Edanz as an editor in November 2011.

Dods先生具有广泛的科学背景和国际背景，拥有在中国和日本工作从事项目工作的经历，项目内容包括：橡胶化合物特征研究（位于日本平冢的横滨橡胶公司）；开发环境分析用的认证基准材料（位于日本筑波的国家先进工业科学和技术研究所）。目前作为研究生，从事生物加工过程的静电纤维研究，这是伦敦大学学院“先进生化工程中心”与英国科学与技术设施理事会位于迪德科特的“微纳米技术中心”之间合作项目的一部分，目的是通过化学功能化处理纳米纤维垫以及允许离子交换组、蛋白质或酶固定化来开发生物分子下游加工中的纯化亲和层析膜。相关应用是组织工程和药物释放领域。DODS先生于2009年加盟理文集团。返回英国之前，曾有一年的时间在理文编辑任专职编辑。

Mr Dods has a broad scientific and international background having worked in China and Japan on projects of characterizing rubber compounds with the Yokohama Rubber Company in Hiratsuka, Japan and developing certified reference materials for environmental analysis with the National Institute of Advanced Industrial Science and Technology in Tsukuba, Japan. Currently, he is a postgraduate researcher investigating electrospun nanofibers for bioprocessing as part of a collaboration between the Advanced Centre of Biochemical Engineering at the University College London, and the Micro and Nanotechnology Centre of the Science and Technology Facilities Council, Didcot, UK. The aim is to develop affinity chromatography membranes for purification in the downstream processing of biomolecules by chemical functionalizing nanofiber mats and allowing ion exchange groups, protein or enzyme immobilization. Relevant applications are in tissue engineering and drug release matrices. Mr Dods joined the Edanz Group in 2009, working for a year as an in-house editor based in Beijing before returning to the UK.

Featured Editor

Pharmacologist with expertise in molecular pharmacology, signal transduction, and neuroscience

Dr Price接受过药理师培训，主要专业是分子药理学、信号传导和神经科学。对促进神经再生的化合物免疫亲和蛋白进行了大量研究。曾在日本、美国和欧洲的医药品和小型生物技术公司工作。发表了20多篇研究文章，其中包括邀稿评审。在过去7年里，已编辑和合作编写了1100多篇科学出版物、发言演示稿和规范性文件。于2008年开始为理文编辑工作，担任编辑。

Dr Price's training is as a pharmacologist, with specific emphasis on molecular pharmacology, signal transduction, and neuroscience. His research includes extensive work on immunophilins, a class of compounds that promote nerve regeneration. He has worked in both pharmaceutical and small biotechnology companies in Japan, the US, and Europe. He has published over 20 research articles, including an invited review. Over the past seven years, Dr Price has edited/co-written over 1100 scientific publications, presentations, and regulatory documents. Dr Price began as an editor with the Edanz Group in 2008.

夸祖鲁纳塔尔大学实验室医学与医学科学学院人体生理系副教授,并在健康科学学院和纳尔逊曼德拉医学院教授人体生理学和人类遗传学，同时还负责基因表达实验室的运作。研究重点：高血压病以及利用药用植物进行控制高血压；先兆子痫的病因与治疗。Mackraj教授的博士后研究工作内容是基因突变近肾端小管细胞模型的生成与表征，用于肾转运机制的研究。目前的研究项目是：降血压植物的研究（重点是血管紧张素系统）、先兆子痫和当地人群的发病机制。另外，还参与了一些新药输送系统的研究项目。经常在ISI列表刊物上发表作品，是多个研究项目基金的主要获奖人。Mackraj教授2011年加盟理文编辑，担任编辑和专家评审。

Prof Mackraj is an Associate Professor in the Discipline of Human Physiology, School of Laboratory Medicine and Medical Sciences, University of Kwazulu-Natal. She teaches Human Physiology and Human Genetics at the Faculty of Health Sciences and the Nelson R Mandela School of Medicine. She is responsible for running a gene expression laboratory. Her main research focuses are hypertension and its management using medicinal plants; and the etiology and treatment of pre-eclampsia. Prof Mackraj’s postdoctoral work involved the generation and characterization of a gene-disrupted proximal tubular cell model for the investigation of transporter mechanisms in the kidney. Her current research projects involve the investigation of blood pressure lowering plants with a focus on the renin-angiotensin system; and the etiopathology of pre-eclampsia in the local population. She is also a participant in projects involving novel drug delivery systems. She is a well-published author in ISI-listed journals, and is the Principle grant-holder for her research projects. Prof Mackraj joined the Edanz Group as an editor and reviewer in 2011.

Dr Nana的研究课题是亨廷顿氏舞蹈症中人类大脑皮层细胞消失的方式。她拥有人类组织研究的经验，擅长人脑库建立、脑组织细胞研究（组织学和免疫组织学）、分子生物学（蛋白质印迹和原位杂交）、显微镜学（明视野、荧光和共焦）及量化分析（体视学和形态分析）。她的研究重点是神经退行性疾病，目前任博士后研究员。Dr Nana曾在同行评审期刊中发表文章并多次出席国际会议。2011年开始为理文编辑工作。

Dr Nana's PhD research focused on the pattern of cell loss in the human cerebral cortex in Huntington's disease. Dr Nana has experience in human tissue studies with skills in human brain banking, cellular studies of human tissue (histology and immunohistochemistry), molecular biology (western blotting and in-situ hybridization), microscopy (brightfield, fluorescence and confocal) and quantitative analysis (stereology and morphometric analyses). Her research focus is neurodegeneration and she is currently a post-doctoral research fellow. Dr Nana has published in peer-reviewed journals and has presented at many international conferences. She joined the Edanz Group as an editor in 2011.

Garcia女士拥有日本北海道大学生物系统可持续发展硕士学位，主攻生物有机化学，现正在攻读新西兰奥克兰大学食品科学博士。主要从事风味与香气化学的研究，完成了果蔬芳气特征的研究工作。研究内容包括挥发性和非挥发性化合物的隔离、GC-MS和NMR等仪器的使用以及酶的使用。曾在日本、新西兰和中国举行的会议上发表研究成果。拥有生命科学领域的广泛背景，包括生物活性化合物和酶的隔离与特性。具有日语和西班牙语的读写能力。于2011年加入理文编辑。

Ms Garcia obtained an MSc in Bio-Systems Sustainability, specializing in Bioorganic Chemistry, from Hokkaido University, Japan, and is currently a PhD candidate in Food Science at the University of Auckland, New Zealand. Her research is focused on flavor and fragrance chemistry, and she has worked on the characterization of the aroma profiles of flowers and fruits. Her work involves the isolation of volatile and non-volatile compounds, the use of instrumentation (GC-MS, NMR, etc.), and the use of enzymes. She has presented her research at conferences in Japan, New Zealand and China. Ms Garcia also has a broad background in the life sciences, including the isolation and characterization of bioactive compounds and enzymes. She is fluent in English, and speaks and reads Japanese and Spanish. She joined the Edanz Group as an editor in 2011.